senate Bill S1976A

Amended

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund

download pdf

Sponsor

Co-Sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 09 / Jan / 2013
    • REFERRED TO HEALTH
  • 22 / May / 2013
    • AMEND AND RECOMMIT TO HEALTH
  • 22 / May / 2013
    • PRINT NUMBER 1976A
  • 08 / Jan / 2014
    • REFERRED TO HEALTH
  • 10 / Feb / 2014
    • AMEND AND RECOMMIT TO HEALTH
  • 10 / Feb / 2014
    • PRINT NUMBER 1976B

Summary

Provides a program to promote leukemia, lymphoma and myeloma research, education and treatment and establishes the leukemia, lymphoma and myeloma research, education and treatment fund; authorizes the commissioner of taxation and finance to create a check-off gift on individual income tax returns for contributions to leukemia, lymphoma and myeloma research, education and treatment.

do you support this bill?

Bill Details

See Assembly Version of this Bill:
A558A
Versions:
S1976
S1976A
S1976B
Legislative Cycle:
2013-2014
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add Art 27-CCC §2747, Pub Health L; add §§209-I & 630-d, Tax L; add §97-llll, St Fin L
Versions Introduced in Previous Legislative Cycles:
2011-2012: S569A, A283A
2009-2010: S1197A, A3075A
2007-2008: S3097B, A1558C

Sponsor Memo

BILL NUMBER:S1976A

TITLE OF BILL: An act to amend the public health law, the tax law and
the state finance law, in relation to providing for taxpayer gifts for
leukemia, lymphoma and myeloma research, education and treatment and
establishing the leukemia, lymphoma and myeloma research, education
and treatment fund

PURPOSE OR GENERAL IDEA OF BILL: The purpose of this bill is to
provide easy access to help fund and support Leukemia, Lymphoma, and
Myeloma research, education and treatment.

SUMMARY OF SPECIFIC PROVISIONS: Section 1 - Amends the public health
law by adding a new article 27-CCC. The new article provides the
Commissioner of Health with the powers to: develop programs concerning
Leukemia, Lymphoma, and Myeloma, to accept and expend grants, awards
and other funding, and to enter into contracts necessary for program
development and granting. Section 2 - Amends the law by adding a new
section 209-1. The new section provides for the Commissioner of
Taxation and Finance to include a space on the corporate income tax
return for contributions to Leukemia, Lymphoma, and Myeloma research,
education and treatment. Section 3 - Amends part 2 of article 22 of
the tax law by adding new section 630-d. The new section provides for
the Commissioner of Taxation and Finance to include a space on the
individual income tax return for contributions to Leukemia, Lymphoma,
and Myeloma research, education and treatment. Section 4 - Amends the
state finance law by adding a new section 97-llll. The new section
provides for the establishment of a special fund, consisting of
revenues received under section 209-i and 630-d of the tax law and any
other moneys appropriated, credited or transferred, for Leukemia,
Lymphoma and Myeloma research, education and treatment. The custody of
this fund will be held jointly by the Commissioner of Taxation and
Finance and the Comptroller. Further, the new section provides that
all monies in the fund to be used only for Leukemia, Lymphoma and
Myeloma research, education and treatment programs approved by the
Department of Health. Additionally, the new section provides that the
Comptroller must approve releases of money that are certified by the
Commissioner of Health and that all money in the fund should be used
prior to the end of the fiscal year.

JUSTIFICATION: Research and treatment efforts for many diseases,
including Alzheimer's and breast cancer, have benefited from
additional funding resulting from having a "check-off box" placed on
the individual and corporate income tax returns. Leukemia, Lymphoma
and Myeloma are blood cancers originating in the bone marrow and
correlate with each other because of the unrestrained growth of the
cells and the parallel functions which they possess. Leukemia,
although more common in adults over the age of 64, is still the
leading cause of disease death of children under 15 yrs old, with
Acute Lymphocytic Leukemia (ALL) being the most common form of
Leukemia in children. Treatment advances for Leukemia have proven to
be prevalent in the survival rate over the years, with the survival
rate increasing from 4% in 1960 to 85% in 1999. Lymphoma involves two
particular forms including Non-Hodgkin, which is the fifth most common
cancer in the U.S. and Hodgkin Lymphoma, which mostly affects
adolescents and young adults. Myeloma occurs mostly in people over 60
yrs old with males having a 50% higher chance than females of being


diagnosed. Each year an estimated 106,200 people in the United States
are diagnosed with Leukemia, Lymphoma, or Myeloma. At the present
time, an estimated 670,950 Americans have blood cancers. Approximately
57,500 Americans will die from these hematological malignancies this
year. In New York State alone, there are approximately 6,600 people
diagnosed with a blood cancer each year and 3,500 people will succumb
to this disease.

PRIOR LEGISLATIVE HISTORY: 2012: A.0283-Passed Assembly S.0569- Died
in Senate Health 2011: A.0283- Passed Assembly S.0569- Died in Senate
Health 2010: A,3075-A Died on 3rd Rdg. S.1197-A - Died in Senate
Health 2009: A.3075 Passed Assembly; 2008: A.1558-C Passed Assembly;
S.3097-B - Died in Senate Health 2007: A.1558-A Passed Assembly;
S.3097-A-- Died in Senate. Health 2006: A.3338-A Passed Assembly;
S.2871-A-Died in Senate Health; 2005: A.3338-Passed Assembly; S.2878-A
Died in Senate Health 2004: A.9816-Passed Assembly; S.6491-Died in
Senate Health

FISCAL IMPLICATIONS: Minimal to the state.

EFFECTIVE DATE: This act shall apply to taxable years commencing on or
after January 1, 2015.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 1976--A

                       2013-2014 Regular Sessions

                            I N  S E N A T E

                               (PREFILED)

                             January 9, 2013
                               ___________

Introduced  by  Sens. ROBACH, BRESLIN -- read twice and ordered printed,
  and when printed to be committed to the Committee on Health -- commit-
  tee discharged, bill amended, ordered reprinted as amended and  recom-
  mitted to said committee

AN ACT to amend the public health law, the tax law and the state finance
  law, in relation to providing for taxpayer gifts for leukemia, lympho-
  ma  and myeloma research, education and treatment and establishing the
  leukemia, lymphoma and myeloma research, education and treatment fund

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  The  public health law is amended by adding a new article
27-CCC to read as follows:
                             ARTICLE 27-CCC
LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
SECTION 2747. LEUKEMIA, LYMPHOMA AND  MYELOMA  RESEARCH,  EDUCATION  AND
                TREATMENT.
  S  2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT.  THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A  PROGRAM
TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
MA  AND  MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION, THE COMMIS-
SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
  1. TO PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS  DESIGNED  TO
REDUCE  OR  PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA, LYMPHOMA AND
MYELOMA;
  2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
ATIONS AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS  AS
TO  THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE FUNDS
BY THE STATE FINANCE LAW; AND
  3. TO ENTER INTO CONTRACTS WITHIN THE AMOUNTS  AVAILABLE  THEREFOR  AS
MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00819-03-3

S. 1976--A                          2

  S  2.  The tax law is amended by adding a new section 209-I to read as
follows:
  S  209-I.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO  THOUSAND  FIFTEEN,  A TAXPAYER IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE SUPPORT OF THE LEUKEMIA, LYMPHOMA AND MYELOMA
RESEARCH, EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION  SHALL  BE  IN
ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
OWED  BY  SUCH  TAXPAYER.  THE  COMMISSIONER  SHALL INCLUDE SPACE ON THE
CORPORATE INCOME TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIB-
UTION.   NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL  REVENUES
COLLECTED PURSUANT TO THIS SECTION SHALL BE CREDITED  TO  THE  LEUKEMIA,
LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
USED  ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF
THE STATE FINANCE LAW.
  S 3. The tax law is amended by adding a new section 630-d to  read  as
follows:
  S  630-D.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
ARY  FIRST,  TWO THOUSAND FIFTEEN, AN INDIVIDUAL IN ANY TAXABLE YEAR MAY
ELECT TO CONTRIBUTE TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH,
EDUCATION  AND  TREATMENT  FUND. SUCH CONTRIBUTION SHALL BE IN ANY WHOLE
DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY  SUCH
INDIVIDUAL.  THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL INCOME
TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIBUTION.    NOTWITH-
STANDING  ANY  OTHER PROVISION OF LAW ALL REVENUES COLLECTED PURSUANT TO
THIS SECTION SHALL BE CREDITED TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
RESEARCH,  EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE PURPOSES
ENUMERATED IN SECTION NINETY-SEVEN-LLLL OF THE STATE FINANCE LAW.
  S 4. The state finance law is amended by adding a new section  97-llll
to read as follows:
  S  97-LLLL.  LEUKEMIA,  LYMPHOMA  AND  MYELOMA RESEARCH, EDUCATION AND
TREATMENT FUND. 1. THERE IS HEREBY ESTABLISHED IN THE JOINT  CUSTODY  OF
THE  COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A SPECIAL
FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
TION AND TREATMENT FUND".
  2. SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE  DEPARTMENT
OF  TAXATION  AND  FINANCE,  PURSUANT  TO  THE PROVISIONS OF SECTION TWO
HUNDRED NINE-I AND SECTION SIX HUNDRED THIRTY-D OF THE TAX LAW  AND  ALL
OTHER  MONEYS  APPROPRIATED,  CREDITED,  OR TRANSFERRED THERETO FROM ANY
OTHER FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS  SECTION
SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
THE FUND ACCORDING TO LAW.
  3.  MONIES  OF  THE FUND SHALL BE EXPENDED ONLY FOR LEUKEMIA, LYMPHOMA
AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN  THIS
SECTION,  "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREAT-
MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
ING GRANTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA  RESEARCH,  EDUCATION  AND
TREATMENT,  WHICH,  PURSUANT TO SECTION TWENTY-SEVEN HUNDRED FORTY-SEVEN
OF THE PUBLIC HEALTH LAW, ARE APPROVED  BY  THE  DEPARTMENT  OF  HEALTH.
SUCH  GRANTS  MAY  INCLUDE,  AMONG  OTHERS, GRANTS TO PUBLIC AND PRIVATE
HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
  4. MONIES SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND  WARRANT  OF
THE  COMPTROLLER  ON VOUCHERS APPROVED AND CERTIFIED BY THE COMMISSIONER
OF HEALTH.

S. 1976--A                          3

  5. TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL  ENSURE
THAT  ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO THE
END OF THAT FISCAL YEAR.
  S 5. This act shall take effect immediately and shall apply to taxable
years commencing on or after January 1, 2015.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.